METHOD, SYSTEM, APPARATUS, AND KIT FOR REMOTE THERAPEUTIC DELIVERY
    1.
    发明申请
    METHOD, SYSTEM, APPARATUS, AND KIT FOR REMOTE THERAPEUTIC DELIVERY 审中-公开
    方法,系统,设备和远程治疗手段

    公开(公告)号:US20090131906A1

    公开(公告)日:2009-05-21

    申请号:US12358337

    申请日:2009-01-23

    IPC分类号: A61M25/10

    摘要: A therapeutic delivery catheter system method or kit for delivery of therapeutic to a target location is provided. In various embodiments of the present invention the invention may include a catheter with a therapeutic delivery lumen and a therapeutic delivery orifice. The lumen and the orifice may be in fluid communication with each other and may be configured such that therapeutic delivered therethrough may be done at pressures mimicking pressures existing or otherwise normal at the target locations receiving the therapeutic. In some embodiments the catheter may be part of a kit that may include instructions regarding the proper manner of operation of the catheter. These instructions may include suggested target pressures for therapeutic delivery as well as delivery times, and suggested lengths of time for the device to reside at the target area after delivery to allow for proper uptake of the therapeutic.

    摘要翻译: 提供了用于将治疗剂递送到目标位置的治疗性递送导管系统方法或试剂盒。 在本发明的各种实施例中,本发明可以包括具有治疗性输送腔和治疗性输送孔的导管。 管腔和孔可以彼此流体连通,并且可以被配置成使得通过其传递的治疗可以在模拟接收治疗剂的目标位置处存在或以其他方式正常的压力下进行。 在一些实施例中,导管可以是套件的一部分,其可以包括关于导管的适当操作方式的指令。 这些说明书可以包括用于治疗性递送以及递送时间的建议目标压力,以及设备在递送之后驻留在目标区域的建议时间长度,以允许治疗剂的适当摄取。

    MEDICAL DEVICE FOR VESSEL COMPATIBILITY DURING HIGH PRESSURE INFUSION
    2.
    发明申请
    MEDICAL DEVICE FOR VESSEL COMPATIBILITY DURING HIGH PRESSURE INFUSION 失效
    高压输液过程中血管相容性的医疗装置

    公开(公告)号:US20080039786A1

    公开(公告)日:2008-02-14

    申请号:US11780885

    申请日:2007-07-20

    IPC分类号: A61M25/10

    摘要: The invention provides devices that can be used to deliver a therapeutic agent to a treatment site within the vessel of a patient at increased pressure, while limiting the contact with and pressure placed on the vessel walls. Devices according to the invention include an expandable structure arranged around and on a tube having a lumen. The expandable structure may include a sealing ring that makes contact with the interior surface of a vessel to prevent or decrease fluid flow during delivery of a therapeutic agent. This allows delivery of a therapeutic agent with decreased risk of injury to the treatment site. The invention also provides for large lumen diameters, preventing shearing stress on therapeutic agents such as cell slurries.

    摘要翻译: 本发明提供了可用于将治疗剂递送到患者血管内的治疗部位的装置,所述治疗部位在增加的压力下同时限制与血管壁上的接触和压力。 根据本发明的装置包括布置在具有内腔的管周围和管上的可扩张结构。 可膨胀结构可包括与血管内表面接触以防止或减少递送治疗剂期间的流体流动的密封环。 这允许递送具有降低治疗部位损伤风险的治疗剂。 本发明还提供大的管腔直径,防止治疗剂如细胞浆液的剪切应力。

    DELIVERY DEVICE WITH PRESSURE CONTROL
    3.
    发明申请
    DELIVERY DEVICE WITH PRESSURE CONTROL 审中-公开
    具有压力控制的输送装置

    公开(公告)号:US20080147007A1

    公开(公告)日:2008-06-19

    申请号:US11612542

    申请日:2006-12-19

    IPC分类号: A61M1/00 B65D71/00

    摘要: Delivery devices with pressure control mechanisms are described herein. In some embodiments an apparatus includes a reservoir configured to contain a fluid, the reservoir having an inlet port and an outlet port. A plunger is disposed within the reservoir such that the reservoir is divided into a first portion and a second portion. The inlet port is in fluid communication with the first portion of the reservoir, and the outlet port is in fluid communication with the second portion of the reservoir. A pressure control device configured to control a pressure of the fluid within the first portion of the reservoir is in fluid communication with the first portion of the reservoir.

    摘要翻译: 具有压力控制机构的输送装置在这里被描述。 在一些实施例中,一种装置包括构造成容纳流体的储存器,储存器具有入口端口和出口。 柱塞被设置在储存器内,使得储存器被分成第一部分和第二部分。 入口与储存器的第一部分流体连通,并且出口与储存器的第二部分流体连通。 被配置为控制储存器的第一部分内的流体的压力的压力控制装置与储存器的第一部分流体连通。

    LOCAL CONTROL OF INFLAMMATION
    4.
    发明申请
    LOCAL CONTROL OF INFLAMMATION 审中-公开
    炎症的局部控制

    公开(公告)号:US20100092448A1

    公开(公告)日:2010-04-15

    申请号:US12642300

    申请日:2009-12-18

    摘要: A medical device includes a carrier and an agent. The agent is formulated to control inflammation of biological tissue, such as heart tissue, and is releasably coupled to the carrier. The carrier is configured to be disposed in operative proximity to the biological tissue to be treated by the agent. In one embodiment, the carrier is configured to release the agent or otherwise deliver the agent to the biological tissue, thus controlling inflammation of the tissue. Also, a method to improve healing of biological tissue includes placing a medical device proximate to the heart of a patient, where the medical device has a carrier and an agent configured to control inflammation, the agent is releasably coupled to the carrier. In one embodiment, the method includes causing the agent to be released from the carrier.

    摘要翻译: 医疗器械包括载体和药剂。 制剂用于控制诸如心脏组织的生物组织的炎症,并且可释放地联接到载体上。 载体被配置为设置在操作中接近要由药剂处理的生物组织。 在一个实施方案中,载体被配置为释放试剂或以其它方式将试剂递送到生物组织,从而控制组织的炎症。 此外,改善生物组织愈合的方法包括将医疗装置放置在靠近患者心脏的位置,其中医疗装置具有载体和被配置成控制炎症的药剂,药剂可释放地联接到载体上。 在一个实施例中,该方法包括使得试剂从载体释放。

    Implantable Drug Depot for Intrathecal Drug Delivery System for Pain Management
    6.
    发明申请
    Implantable Drug Depot for Intrathecal Drug Delivery System for Pain Management 审中-公开
    用于疼痛管理的鞘内药物递送系统的植入药物库

    公开(公告)号:US20090123508A1

    公开(公告)日:2009-05-14

    申请号:US12245311

    申请日:2008-10-03

    IPC分类号: A61K9/00 A61K47/30 A61P29/00

    摘要: The present disclosure provides an intrathecally-implantable depot having a biodegradable core for extended release of pain-relieving drug into the intrathecal space over at time period of at least a month. The present disclosure further provides methods for preparing a self-contained intrathecally-implantable depot and methods for continuously relieving pain in a subject by implanting an intrathecally-implantable depot having a biodegradable core and releasing a therapeutically-effective amount of analgesic composition from the biodegrading core over a time period of at least one month.

    摘要翻译: 本公开提供了一种具有可生物降解的芯的鞘内可植入的贮存库,用于在至少一个月的时间段上将疼痛缓解药物延长释放到鞘内空间中。 本公开进一步提供了用于制备自包含鞘内可植入储存库的方法和通过植入具有生物可降解核心的鞘内可植入的贮存库并且从生物降解核心释放治疗有效量的镇痛组合物来连续缓解受试者的疼痛的方法 在至少一个月的时间内。